Health Conditions

Usually, babies receive natural substances to help fight RSV and other viruses, called antibodies, from their mothers. If a baby is born prematurely, the baby does not get enough of these virus-fighting antibodies before birth. Synagis and RespiGam provide the natural antibodies that specifically target RSV. Synagis is recommended for prevention of serious RSV infections in infants with bronchopulmonary dysplasia (BPD - a chronic lung disease often seen in premature infants) and infants with a history of premature birth (birth before 35 weeks gestation). RespiGam is recommended for prevention of serious RSV infections in infants less than 24 months of age with BPD and infants with a history of prematurity. Synagis and RespiGam are injections, typically given once a month during the RSV season (November through May). One injection protects the baby for one month, so an injection is needed every month during the RSV season to be fully protected.

<< Back

Note: The above information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist, or other healthcare professional. It is not intended to diagnose a health condition, but it can be used as a guide to help you decide if you should seek professional treatment or to help you learn more about your condition once it has been diagnosed.